February 13, 2015 – IGPA has filed its inaugural submission with the Office of the United States Trade Representative (USTR) as part of USTR`s 2015 Special 301 Review. The IGPA submission identifies a number of trade barriers and impediments for the generic pharmaceutical and biosimilar medicines industries.
January 26, 2015 - The International Hospital Federation (IHF) and the International Generic Pharmaceutical Alliance (IGPA) endorse efforts by organizations representing patients, health professionals and R&D pharma to recognize common ethical principles worldwide when delivering solutions to address patients’ needs. Global movement fostering ethical practices celebrates first anniversary of its Consensus Framework, showing progress at national level. The Consensus Framework can be referred to by health providers and has the potential to impact millions of patients worldwide.
MIAMI, FLORIDA (November 19, 2014) — Today, the International Generic Pharmaceutical Alliance (IGPA) commences its 17th Annual Conference, bringing together company executives, regulators, national authorities and other global leaders in the generic drug industry.
- IGPA calls for equal status for generics industry at global pharmaceutical standards organization meeting
- IGPA submits formal request to global pharmaceutical standards-setting organization seeking equal status for generics industry
- IGPA organizes its 16 Annual Conference in Brussels
- IGPA Letter Regarding TGA Guidance titled “Evaluation of Biosimilars”
